Clinical Trials Browser

Unknown × Interventional × Immunotherapy, Adoptive × Clear all

NCT06724835 2024-12-09

Treating Nectin-4-positive Advanced Breast Cancer with XKDCT293 (Nectin-4-CAR-T)

Phase 1 Unknown

Advanced Breast Cancer

NCT03291444 2024-03-15

CAR-T Cells Combined With Peptide Specific Dendritic Cell in Relapsed/Refractory Leukemia/MDS

Phase 1 Unknown

MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT06238336 2024-02-02

Clinical Study of CAR-T Technology for the Treatment of Relapsed Refractory Malignant Haematological Tumours

Phase 2/3 Unknown

Other hematologic neoplasm

Hematologic Neoplasms

NCT05420493 2024-01-05

Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Relapsed/Refractory Non-Hodgkin Lymphoma

Phase 1 Unknown

Lymphoma, Non-Hodgkin

NCT05783076 2023-08-30

SBRT Plus vNKT for Pancreatic Cancer

Phase 2 Unknown

Gastrointestinal

Pancreatic Neoplasms

NCT05979792 2023-08-21

Clinical Study of CD7 CAR-T Cell Injection in the Treatment of Patients With Relapsed or Refractory CD7-positive Peripheral T Cell Lymphoma

Phase EARLY_PHASE1 Unknown

Lymphoma, T-Cell, Peripheral

NCT05089266 2023-07-17

Study of αPD1-MSLN-CAR T Cells to Evaluate the Safety, Tolerability, and Effectiveness for Patients With MSLN-positive Advanced Solid Tumors

Phase 1 Unknown

Gastrointestinal

Colorectal Neoplasms

NCT05748938 2023-03-01

A Study of RD14-01 in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumor

NCT03467256 2023-02-24

CD19 T-CAR for Treatment of Children and Young Adults With r/r B-ALL

Phase 1/2 Unknown

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05654077 2022-12-19

EBV CAR-T Cells for Nasopharyngeal Carcinoma

Phase EARLY_PHASE1 Unknown

Nasopharyngeal Carcinoma

NCT04609215 2022-04-20

ImmunoBreast - A Phase Ib Study

Phase 1/2 Unknown

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05312476 2022-04-05

Clinical Study on CAR-T Targeting Igβ Targets in Refractory Relapsed Non-Hodgkin's Lymphoma

Phase 2 Unknown

Lymphoma, B-Cell

NCT05248048 2022-02-21

NKG2D CAR-T Cells to Treat Patients With Previously Treated Liver Metastatic Colorectal Cancer

Phase EARLY_PHASE1 Unknown

Gastrointestinal

Colorectal Neoplasms

NCT03423992 2021-06-15

Personalized Chimeric Antigen Receptor T Cell Immunotherapy for Patients With Recurrent Malignant Gliomas

Phase 1 Unknown

Glioma, Recurrence

NCT04790747 2021-03-10

Sequential Radiotherapy With CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies With Extramedullary Lesions

Phase 1/2 Unknown

Other hematologic neoplasm

Recurrence, Hematologic Neoplasms

NCT04692948 2021-03-08

TAA6 Cell Injection In The Treatment of Patients With Relapsed / Refractory Acute Myeloid Leukemia

Phase NA Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04121273 2021-03-03

GPC3-targeted CAR-T Cell for Treating GPC3 Positive Advanced HCC

Phase 1 Unknown

Gastrointestinal

Simpson-Golabi-Behmel syndrome, Carcinoma, Hepatocellular

NCT02186860 2021-02-10

Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With Acute Lymphoblastic Leukemia

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03932565 2020-11-18

Interventional Therapy Sequential With the Fourth-generation CAR-T Targeting Nectin4/FAP for Malignant Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Nectin4-positive Advanced Malignant Solid Tumor

NCT04534634 2020-09-01

Study of IFN-α Combined With CAR-T Cell Therapy in Relapsed and Refractory Acute Lymphoblastic Leukemia（R/R-ALL）

Phase 2 Unknown

Burkitt Lymphoma

NCT04206943 2020-01-27

ISIKOK-19

Phase 1/2 Unknown

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03638206 2019-12-11

Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies

Phase 1/2 Unknown

CNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidOther hematologic neoplasmOther solid neoplasmPlasma cellSarcomaThoracic

Burkitt Lymphoma, Carcinoma, Renal Cell, Esophageal Neoplasms, Glioma, Carcinoma, Hepatocellular, Leukemia, Myeloid, Lung Neoplasms, Lymphoma, Melanoma, Mesothelioma, Multiple Myeloma, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Sarcoma, Synovial, Colorectal Neoplasms

NCT03271632 2019-09-19

Multi-CAR T Cell Therapy in the Treatment of Multiple Myeloma

Phase 1/2 Unknown

Multiple Myeloma

NCT03598179 2019-08-07

XLCART001 Treatment in Relapsed/Refractory/High-risk B-cell Malignancy Subjects

Phase 2 Unknown

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, B-Cell

NCT02965092 2019-05-10

CD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With B-cell Malignancies

Phase 1/2 Unknown

LymphoidOther hematologic neoplasm

Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03881774 2019-03-21

Cord Blood Derived CAR-T Cells in Refractory/Relapsed B Cell Malignancies

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell

NCT03525782 2018-05-16

Anti-MUC1 CAR T Cells and PD-1 Knockout Engineered T Cells for NSCLC

Phase 1/2 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03013712 2017-01-06

CARTEPC

Phase 1/2 Unknown

GastrointestinalGenitourinary

Colonic Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms

NCT02980315 2016-12-02

A New EBV Related Technologies of T Cells in Treating Malignant Tumors and Clinical Application

Phase 1/2 Unknown

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

NCT02959151 2016-11-08

A Study of Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy

Phase 1/2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular

NCT02819583 2016-10-25

CAR-T Cell Immunotherapy in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma

Phase 1/2 Unknown

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Prolymphocytic, B-Cell

NCT02851589 2016-08-01

Study Evaluating the Efficacy and Safety of PCAR-019 in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma

Phase 1/2 Unknown

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Prolymphocytic, B-Cell

NCT02315118 2016-06-22

Pilot Study of Autologous T Lymphocytes With ADCC in Patients With CD20-Positive B-Cell Malignancies

Phase 1/2 Unknown

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell

NCT01864902 2016-01-28

CART33

Phase 1/2 Unknown

Other hematologic neoplasm

Leukemia, Myeloid

NCT01886976 2016-01-28

CART-138

Phase 1/2 Unknown

Multiple Myeloma